Department of Justice Investigation
Following the worldwide recalls and ban by the United States Food and Drug Administration (FDA) of antacid medicine Zantac, the Department of Justice announced it is investigating GlaxoSmithKline (GSK) and Sanofi for potential violations of the False Claims Act. The False Claims Act (FCA) is also known as the “Lincoln Law”. It is a federal law of the United States that that imparts liability on people and companies (usually federal contractors) who defraud government programs. It is the primary tool of the Federal Government to combat fraud. The probe related to Zantac relates to an alleged failure of the drugmakers to properly and/or accurately report information about a potential carcinogen in the drugs to the federal government.